Abstract
We support the conclusions of this thoughtful editorial comment. Although our long-term review of laparoscopic cryoablation demonstrates cancer recurrence rates that are higher than those reported for partial nephrectomy, 1 Klatte T. Grubmüller B. Waldert M. et al. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol. 2011; 60: 435-443 Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar , 2 Novara G. Ficarra V. Is laparoscopic cryoablation a less invasive and effective procedure to treat small renal masses?. Eur Urol. 2011; 60 (discussion 446-447): 444-445 Abstract Full Text Full Text PDF PubMed Scopus (6) Google Scholar with appropriate follow-up and treatment of recurrences, our 6-year cancer-specific survival was 100%. Our data support a role for cryoablation in select comorbid patients, as suggested in the editorial review as well as published American Urological Association (AUA) guidelines. 3 Campbell S.C. Novick A.C. Belldegrun A. et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009; 182: 1271-1279 Abstract Full Text Full Text PDF PubMed Scopus (1502) Google Scholar Editorial CommentUrologyVol. 80Issue 2PreviewThis excellent long-term analysis of laparoscopic cryoablation of renal cell carcinoma brings to light some of the important advantages and disadvantages all practicing urologist should be aware of. Sixty-two patients with biopsy proven renal cell carcinoma were followed with magnetic resonance imaging (MRI) for on average over 6 years (76 months). Disease-free survival was a laudable 80%, cancer-specific survival 100%, and overall survival 76.2% in this group of patients, who obviously had other comorbidities making them candidates for laparoscopic renal cryoablation. Full-Text PDF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.